Renaissance Technologies (RenTech)'s PALI Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 1.12 M shares of Palisade Bio, Inc. (PALI) worth $2.35 M, representing 0.00% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in PALI, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 2.38 M shares. Largest reduction occurred in Q1 2026, reducing 928,100 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Palisade Bio (PALI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Palisade Bio (PALI) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -329,600 | Reduce 22.66% | 1.12 M | $2.09 |
| Q1 2026 | -928,100 | Reduce 38.95% | 1.45 M | $1.75 |
| Q4 2025 | +2.38 M | New Buy | 2.38 M | $2.35 |
| Q4 2022 | -683 | Sold Out | 0 | $0.00 |
| Q3 2022 | +637 | Add 1384.78% | 683 | $74.67 |
| Q2 2022 | +18 | Add 64.29% | 46 | $304.35 |
| Q1 2022 | -80 | Reduce 74.07% | 28 | $821.43 |
| Q4 2021 | +108 | New Buy | 108 | $972.22 |
| Q3 2021 | -194 | Sold Out | 0 | $0.00 |
| Q2 2021 | +194 | New Buy | 194 | $3046.39 |
Renaissance Technologies (RenTech)'s Palisade Bio Investment FAQs
Renaissance Technologies (RenTech) first purchased Palisade Bio, Inc. (PALI) in Q2 2021, acquiring 194 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Palisade Bio, Inc. (PALI) for 10 quarters since Q2 2021.
Renaissance Technologies (RenTech)'s largest addition to Palisade Bio, Inc. (PALI) was in Q4 2025, adding 2,382,500 shares worth $5.6 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 1,124,800 shares of Palisade Bio, Inc. (PALI), valued at approximately $2.35 M.
As of the Q2 2026 filing, Palisade Bio, Inc. (PALI) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Palisade Bio, Inc. (PALI) was 2,382,500 shares, as reported at the end of Q4 2025.